Precision Biosciences (DTIL) EPS (Basic) Growth (3y) (2021 - 2026)
Precision Biosciences (DTIL) EPS (Basic) Growth (3y) (2021 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
EPS (Basic) Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
-27.25% |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
139.68% |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
25.99% |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
85.94% |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
41.58% |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
14.28% |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Precision Biosciences |
168.99 Mn |
67.81 Mn |
- |
51.93% |
| Date | Value |
|---|
| Mar 31, 2026 |
51.93% |
| Dec 31, 2025 |
28.22% |
| Sep 30, 2025 |
-135.99% |
| Jun 30, 2025 |
-66.68% |
| Mar 31, 2025 |
-68.74% |
| Dec 31, 2024 |
-95.05% |
| Sep 30, 2024 |
-127.93% |
| Jun 30, 2024 |
131.26% |
| Mar 31, 2024 |
92.66% |
| Dec 31, 2023 |
57.22% |
| Sep 30, 2023 |
-84.69% |
| Jun 30, 2023 |
-70.63% |
| Mar 31, 2023 |
-135.02% |
| Dec 31, 2022 |
-304.58% |
| Sep 30, 2022 |
30.10% |
| Jun 30, 2022 |
-5.66% |
| Mar 31, 2022 |
38.63% |
| Dec 31, 2021 |
27.08% |
| Sep 30, 2021 |
32.58% |
| Jun 30, 2021 |
35.84% |
